Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 2 study of CS20AT04 in lupus nephritis or lupus cytopenia
KCT0004337Phase 2Recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Nov 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CS20AT04 in systemic lupus erythematosus (SLE), lupus nephritis (LN), cytopenia, sponsored by Ministry of Health & Welfare. Started Nov 2019; status: recruiting.
02
Drugs
CS20AT04
03
Conditions
systemic lupus erythematosus (SLE)lupus nephritis (LN)cytopenia
Beyond the preview
Go deeper on KCT0004337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004337.